RBM3 expression loss is associated with right-sided localization and poor prognosis in colorectal cancer

被引：0
|
作者：
Marx, A. H. [1 ]
Simon, R. [1 ]
Lzbicki, J. R. [2 ]
Terracciano, L. [3 ]
Bokemeyer, C. [4 ]
Sauter, G. [1 ]
Melling, N. [2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Pathol, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Surg, Hamburg, Germany
[3] Univ Basel Hosp, Pathol, CH-4031 Basel, Switzerland
[4] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Canc Ctr, BMT Sect Pneumol, Dept Oncol,Hematol, Hamburg, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P209
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer
    Melling, Nathaniel
    Simon, Ronald
    Mirlacher, Martina
    Izbicki, Jakob R.
    Stahl, Philip
    Terracciano, Luigi M.
    Bokemeyer, Carsten
    Sauter, Guido
    Marx, Andreas H.
    [J]. HISTOPATHOLOGY, 2016, 68 (02) : 191 - 198
  • [2] High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer
    Hjelm, Barbara
    Brennan, Donal J.
    Zendehrokh, Nooreldin
    Eberhard, Jakob
    Nodin, Bjorn
    Gaber, Alexander
    Ponten, Fredrik
    Johannesson, Henrik
    Smaragdi, Kristina
    Frantz, Christian
    Hober, Sophia
    Johnson, Louis B.
    Pahlman, Sven
    Jirstrom, Karin
    Uhlen, Mathias
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (11-12) : 624 - 635
  • [3] Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer
    Dong, Wenjie
    Li, Na
    Pei, Xiufeng
    Wu, Xinai
    [J]. ONCOLOGY LETTERS, 2018, 15 (04) : 4207 - 4214
  • [4] Decreased expression of RBM3 correlates with tumour progression and poor prognosis in urinary bladder cancer
    Boman, K.
    Ahlgren, G.
    Segersten, U.
    Eberhard, J.
    Ponten, F.
    Uhlen, M.
    Jirstrom, K.
    Malmstrom, P-U
    [J]. HISTOPATHOLOGY, 2012, 61 : 147 - 147
  • [5] Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
    Brennan, D. J.
    Ehlen, A.
    McGee, S.
    O'Connor, D. P.
    Jirstrom, K.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S60 - S61
  • [6] Expression of the translation regulatory protein RBM3 is associated with a favourable prognosis in epithelial ovarian cancer
    Asa, Ehlen
    Brennan, Donal J.
    Alvarado-Kristensson, Maria
    Nodin, Bjorn
    O'Connor, Darran J.
    Uhler, Mathias
    Ponten, Fredrik
    Jirstrom, Karin
    [J]. CANCER RESEARCH, 2010, 70
  • [7] High nuclear expression of RBM3 is associated with an improved prognosis of clinical outcome in breast cancer
    Kwon, S. Y.
    Kang, S. H.
    Kang, Y. N.
    Choe, M.
    Hwang, I.
    Cho, J. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S117 - S117
  • [8] High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
    Siesing, Christina
    Sorbye, Halfdan
    Dragomir, Anca
    Pfeiffer, Per
    Qvortrup, Camilla
    Ponten, Fredrik
    Jirstrom, Karin
    Glimelius, Bengt
    Eberhard, Jakob
    [J]. PLOS ONE, 2017, 12 (08):
  • [9] High expression of RBM3 in colorectal cancer is a predictor of improved response to oxaliplatin treatment
    Jonsson, L.
    Fridberg, M.
    Wangefjord, S.
    Nodin, B.
    Uhlen, M.
    Eberhard, J.
    Jirstrom, K.
    [J]. HISTOPATHOLOGY, 2012, 61 : 82 - 83
  • [10] Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
    Herold, Zoltan
    Dank, Magdolna
    Herold, Magdolna
    Nagy, Peter
    Rosta, Klara
    Somogyi, Aniko
    [J]. CANCERS, 2021, 13 (01) : 1 - 15
12345